Literature DB >> 16146481

Cardiac tamponade and septic shock caused by viral infection in a previously healthy woman.

J J Laurila1, T I Ala-Kokko, H Tuokko, H Syrjälä.   

Abstract

A previously healthy woman was admitted to hospital after 'flu-like' symptoms for 5 days followed by acute intense abdominal and lower back pain. On admission she was found to be in severe shock and was transferred to the ICU. Echocardiography revealed cardiac tamponade, and pericardiocentesis was performed immediately. Thereafter her cardiovascular state improved, but she developed hypotension with low systemic vascular resistance and required vasoactive treatment for 4 days. Nine days after admission the patient was transferred to the ward, after which she recovered rapidly and completely. The cause of her illness was extensively screened. No underlying disease was found, and all bacterial cultures remained negative. Acute virus infection was confirmed by diagnostic elevations of antibody titers to Influenza A and adenovirus. Adenovirus was also isolated from her bronchoalveolar lavage fluid.

Entities:  

Mesh:

Year:  2005        PMID: 16146481     DOI: 10.1111/j.1399-6576.2005.00748.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  3 in total

1.  Right and left heart failure in severe H1N1 influenza A infection.

Authors:  S M Brown; J Pittman; R R Miller Iii; K D Horton; B Markewitz; E Hirshberg; J Jones; C K Grissom
Journal:  Eur Respir J       Date:  2010-06-01       Impact factor: 16.671

Review 2.  Influenza Myopericarditis and Pericarditis: A Literature Review.

Authors:  Milan Radovanovic; Marija Petrovic; Michel K Barsoum; Charles W Nordstrom; Andrew D Calvin; Igor Dumic; Dorde Jevtic; Richard D Hanna
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

Review 3.  Viruses in the Heart: Direct and Indirect Routes to Myocarditis and Heart Failure.

Authors:  Colton R Martens; Federica Accornero
Journal:  Viruses       Date:  2021-09-24       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.